Luke Hansen, M.D., M.H.S., and chief medical officer of Arcadia, a healthcare data analytics company, said that achieving value-based care will need to be a multipronged approach with commercial purchasers and state Medicaid programs playing a prominent role.
The future of value-based care under the current Trump administration depends on a variety of factors, according to Luke Hansen, M.D., M.H.S., and chief medical officer of Arcadia.
Luke Hansen, M.D., M.H.S.
“Changes in administration are an opportunity to reexamine the success of previous programs,” Hansen said in a video interview with Managed Healthcare Executive. “My take on it is that it's going to take a recipe, it's going to take a mix, because you need incentives for PCPs, but you also need additional incentives for specialists that haven't existed yet, and you need incentives for other kinds of key stakeholders in the industry.”
He explained his point further by using a multihospital health system as an example.
“So, a multihospital health system, have they really been incentivized to chase total cost of care? And how can we build a program that will do that?” “Because the Medical Shared Savings Programs and the other Accountable Care Organizations iterations since then, there are savings that absolutely accrue to Medicare, but when those savings are taken out of the revenue stream of the sponsor organization, there's a tension there that I wish we could get past. How can we set up a system where all the stakeholders benefit through more efficient care?”
Hansen also mentioned the important role states play in the Medicaid program.
If [states’] overall revenue availability for Medicaid starts to shrink, the states are going to have to be creative, and that might be a driver of value-based care,” Hansen said. “Hopefully the states can be stewards in the Medicaid program with flexibilities that they didn't have before.
Increased Risk of Severe RSV Illness in Adults With Asthma or COPD
March 19th 2025Historically, RSV has been studied mainly in infants and older adults, but recent research shows that it also poses a significant threat to adults with asthma and COPD. However, research on the virus within these groups has been limited.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Study Finds Adherence to Annual Lung Cancer Screening Linked to Higher Detection Rates
March 18th 2025Researchers found that adherence to the first and second annual screenings was 61% and 51%, respectively, with higher lung cancer detection rates observed in those who followed through on these screenings.
Read More